Similarly, Cheng et al. found that administration of metformin (an AMPK activator which inhibits mTOR) successfully diminished inflammation, alveolar destruction and cellular senescence in CS-induced COPD [235]. Here, MTOR is linked to chronic obstructive pulmonary disease.